-
40 pharmaceutical and biological concept stocks rose by more than 10% during the year, focusing on medical devices, traditional Chinese medicine and other tracks
Time of Update: 2022-09-06
Among them, the net profit growth rate of Dongbao Biological is a focus on the whole industry chain of natural collagen enterprises, semi-annual report shows that in the first half of the year, the company continued to focus on the "collagen +" strategic layout, continue to increase the promotion of terminal series of new products listing, with foreign investment as the starting point, improve brand and channel construction, establish a three-dimensional sales promotion network, terminal business to achieve new breakthroughs.
-
Under the accelerated fundraising and expansion of pharmaceutical equipment leading enterprises, the market competitiveness will continue to improve
Time of Update: 2022-09-06
In April, Canaan Technology also announced that it intends to invest 50 million yuan in its own funds to establish a wholly-owned subsidiary, Tianjin Canaan Biomedical Equipment Co.
-
There is a consensus on off-label medication!
Time of Update: 2022-09-06
On August 25, the Shandong Pharmaceutical Association issued the "Shandong Province Expert Consensus on Drugs with Off-label Drugs (2022 Edition)" . Off- label drug use is common in actual clinical p
-
13 departments have introduced policies and measures to support the elderly care service industry
Time of Update: 2022-09-06
The reporter learned on the 30th that 13 departments including the National Development and Reform Commission recently issued a notice on "Several Policies and Measures for Relief and Support of the Pension and Nursing Service Industry", which clarified rent reduction and exemption, tax reduction and exemption, social insurance support, financial support, epidemic prevention support and Other support and other 26 relief and support measures .
-
Gene drugs will become another pillar in the field of medicine Related industrial chains are expected to benefit
Time of Update: 2022-09-06
Gene drugs will become another pillar of the pharmaceutical field Related industry chain is expected to benefit (image source: pharmaceutical network) Data show that in recent years, the global gene drug market size has continued to grow, since 2021 will maintain a growth rate of more than 65%, is expected to exceed 30 billion US dollars by 2025.
-
The 2022 vaccine NRA assessment covers the entire regulatory chain
Time of Update: 2022-09-06
standard On August 23, 2022, the World Health Organization (WHO) announced that China has passed the assessment of the National Regulatory System (NRA) for vaccines .
standard On August 23, 2022, the World Health Organization (WHO) announced that China has passed the assessment of the National Regulatory System (NRA) for vaccines .
-
What is the future situation of the pharmaceutical sector? In the industry: the bottom has a bottom, and the upper can be expected
Time of Update: 2022-09-06
This direction is conducive to the weakening of homogeneous competition among pharmaceutical companies, so that the industry's capital, technology, clinical and other resources are concentrated in the head of innovative enterprises, and the concentration of the entire innovative drug research and development industry is expected to increase.
-
Miracle of Mind: Stroke Sequela BATA Conditioning!
Time of Update: 2022-09-06
Patients need long-term medication, even if the most advanced treatment methods are currently available, more than 50% of them are still unable to take care of themselves, and 30% are at risk of recurrence!The sequelae of stroke mainly include: half-body failure, limb numbness, sensory impairment, language impairment, memory loss, crooked mouth and eyes, ataxia, dizziness and headache.
-
Are diabetes drugs the next profit growth point? Pharmaceutical companies are accelerating their efforts
Time of Update: 2022-09-06
The industry said that with the increase in the number of patients, the increase in per capita disposable income, and the expansion of diabetes drug indications and other factors, in recent years, China's diabetes drug market has shown a growing trend year by year.
-
Traditional Chinese medicine continues to usher in the policy east wind, and the performance of most enterprises has grown significantly
Time of Update: 2022-09-06
Among them, from the performance point of view, as of August 24, 30 Chinese medicine listed companies in A shares have disclosed the first half of the performance report, of which 20 Chinese medicine listed companies have achieved a year-on-year increase in net profit attributable to the mother, accounting for more than 60%.
-
China's ophthalmic medical demand shows a continuous growth trend, the market size or more than 100 billion yuan
Time of Update: 2022-09-06
For example, according to the 2022 semi-annual report released by Xingqi Eye Medicine, in the first half of this year, the company's operating income increased by 29.
-
Kexing Pharmaceutical released its semi-annual report "Innovative R&D + Product Introduction" with remarkable progress
Time of Update: 2022-09-06
On the evening of August 29, Kexing Pharmaceutical (688136. SH) released the 2022 semi-annual report, during the reporting period, the company achieved a total operating income of 629 million yuan, a
-
Innovative drugs have been approved for listing one after another, and pharmaceutical companies are actively accelerating their commercialization
Time of Update: 2022-08-30
For example, Zai Lab said that in terms of commercialization exploration, the company actively cooperated with medical insurance negotiations on the one hand, and strived to allow more innovative treatments to benefit the majority of patients through medical insurance .
-
The tide of new shares breaking is intensifying, and the pharmaceutical and biological sector has become a "hardest hit area"
Time of Update: 2022-08-30
It is reported that Rendu Bio will be listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange on March 30, 2022, with an issue price of 72.
-
The prospect of the pharmaceutical equipment market is improving, and the policy side and the demand side will continue to provide momentum for development
Time of Update: 2022-08-30
Policies and demands are providing continuous development impetus for the pharmaceutical equipment industry (Source: Pharmaceutical Network) Tofflon's 2022 semi-annual performance forecast shows that the net profit attributable to shareholders of listed companies during the reporting period was 391.
-
There are long-term investment opportunities in the pharmaceutical sector, and two high-growth tracks are optimistic
Time of Update: 2022-08-30
However, in the long run, the industry is generally optimistic about investment opportunities in the pharmaceutical sector, and there are two high-growth tracks worthy of attention, including innovative drugs and innovative medical devices .
-
The third batch of centralized procurement in Zhejiang is on the way!
Time of Update: 2022-08-30
According to the data of Minenet, in 2020, the number of lansoprazole in urban public hospitals, counties and Among the terminal types of peptic ulcer medicines in public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions), the sales of lansoprazole exceeded 3 billion yuan .
-
The China Securities Regulatory Commission approves the IPO registration of 3 pharmaceutical companies including Enwei Pharmaceuticals on the Growth Enterprise Market
Time of Update: 2022-08-30
, Ltd. Enwei Pharmaceutical plans to raise 700 million yuan to enhance the competitiveness of its main business Enwei Pharmaceutical was established in May 2005, mainly engaged in the research and development, production and sales of Chinese patent medicines and chemical drugs, focusing on gynecological products, pediatric drugs, respiratory system drugs, etc.
-
The market of 100 billion Chinese medicine formula granules has both opportunities and challenges!
Time of Update: 2022-08-30
With the acceleration of unified standard work and inter-provincial joint procurement, and the continuous release of policy dividends, the market space of traditional Chinese medicine formula granules is widely optimistic .
-
Under the rapid development of traditional Chinese medicine industry, traditional Chinese medicine pharmaceutical equipment urgently needs to develop to high-end
Time of Update: 2022-08-30
From the perspective of the development status of the traditional Chinese medicine pharmaceutical equipment industry, although the traditional Chinese medicine pharmaceutical equipment enterprises have continued to exert their efforts in recent years and the varieties of equipment have been continuously enriched, the overall technology is still relatively weak, lacks independent innovation, and has high energy consumption and low efficiency.
![9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene / 1369431-34-4](https://file.echemi.com/fileManage/upload/goodpicture/20241028/9-3-chloro-5-phenanthren-9-ylphenylphenanthrene-1369431-34-4_b20241028151130118.jpg)
